New therapeutic prospects in HCV treatment (English)
- New search for: Almasio, Piero Luigi
- New search for: Ingrassia, Daniela
- New search for: Vergara, Beatrice
- New search for: Filosto, Sergio
- New search for: Almasio, Piero Luigi
- New search for: Ingrassia, Daniela
- New search for: Vergara, Beatrice
- New search for: Filosto, Sergio
In:
Expert Review of Anti-infective Therapy
;
6
, 6
;
775-779
;
2008
- Article (Journal) / Electronic Resource
-
Title:New therapeutic prospects in HCV treatment
-
Contributors:Almasio, Piero Luigi ( author ) / Ingrassia, Daniela ( author ) / Vergara, Beatrice ( author ) / Filosto, Sergio ( author )
-
Published in:Expert Review of Anti-infective Therapy ; 6, 6 ; 775-779
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2008-12-01
-
Size:5 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 6, Issue 6
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 775
-
New therapeutic prospects in HCV treatmentAlmasio, Piero Luigi / Ingrassia, Daniela / Vergara, Beatrice / Filosto, Sergio et al. | 2008
- 781
-
News in brief| 2008
- 785
-
Atazanavir: its role in HIV treatmentWood, Robin et al. | 2008
- 797
-
Tipranavir: a new protease inhibitor for the pediatric populationCourter, Joshua D / Girotto, Jennifer E / Salazar, Juan C et al. | 2008
- 805
-
Cefepime: a reappraisal in an era of increasing antimicrobial resistanceEndimiani, Andrea / Perez, Federico / Bonomo, Robert A et al. | 2008
- 825
-
Linezolid for the treatment of drug-resistant infectionsHerrmann, David J / Peppard, William J / Ledeboer, Nathan A / Theesfeld, Melissa L / Weigelt, John A / Buechel, Bryan J et al. | 2008
- 849
-
Staphylococcus: Molecular GeneticsTillotson, Glenn S et al. | 2008
- 851
-
Third Advances Against Aspergillosis Meeting 2008Stevens, David A / Clemons, Karl V et al. | 2008
- 855
-
Entecavir monotherapy for lamivudine-refractory chronic hepatitis BGoulis, Ioannis / Dalekos, George N et al. | 2008
- 861
-
Optimal duration of the antimicrobial treatment of ventilator-acquired pneumoniaGrammatikos, Alexandros P / Siempos, Ilias I / Michalopoulos, Argyris / Falagas, Matthew E et al. | 2008
- 867
-
Natural killer cells in immunodefense against infective agentsZucchini, Nicolas / Crozat, Karine / Baranek, Thomas / Robbins, Scott H / Altfeld, Marcus / Dalod, Marc et al. | 2008
- 887
-
Using antimicrobial host defense peptides as anti-infective and immunomodulatory agentsKruse, Thomas / Kristensen, Hans-Henrik et al. | 2008
- 897
-
Measuring the severity of Clostridium difficile infection: implications for management and drug developmentBelmares, Jaime / Gerding, Dale N / Tillotson, Glenn / Johnson, Stuart et al. | 2008
- 909
-
Treatment and recurrence management of staphylococcal infections: community-acquired MRSAKale-Pradhan, Pramodini / Johnson, Leonard B et al. | 2008
- 917
-
Vancomycin resistance: are there better glycopeptides coming?Linden, Peter K et al. | 2008
- 929
-
Management of neonatal sepsis by Gram-negative pathogensVenkatesh, Mohan P / Garcia-Prats, Joseph A et al. | 2008
- 939
-
Treatment of tuberculosis in childrenCruz, Andrea T / Starke, Jeffrey R et al. | 2008
- 969
-
Acknowledgements| 2008